Literature DB >> 30834088

Comparative virulotyping and phylogenomics of Escherichia coli isolates from urine samples of men and women suffering urinary tract infections.

Hamid Staji1, Maryam Rassouli1, Samaneh Jourablou2.   

Abstract

OBJECTIVES: Escherichia coli strains are common pathogens that can cause urinary tract infections (UTI). This study aimed to assess E. coli phylogroups and virulence types in male and female UTI patients.
MATERIALS AND METHODS: In the present study, 160 uropathogenic E. coli (UPEC) isolates (from both sexes) were assigned to phylogroups/types and some extraintestinal virulence factors were detected within them by multiplex-PCR.
RESULTS: The isolates from women and men were predominantly distributed within phylogroup B2 and D, respectively. The presence of D2 phylotype was higher in men isolates than women, significantly (P=0.045). In male isolates papEF and sfa/focDE are more prevalent in B2 group than D, significantly (P=0.048; P=0.035). The prevalence of hly in B2 group is significantly higher than D (P=0.034) in female isolates.
CONCLUSION: This study highlighted different features of E. coli genotypes from phylogenetic and virulence point of view implicated in UTI's in both human genders.

Entities:  

Keywords:  Female; Male; Phylogeny; Urinary tract infections; Uropathogenic Escherichia coli; Virulence

Year:  2019        PMID: 30834088      PMCID: PMC6396991          DOI: 10.22038/ijbms.2018.28360.6880

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


Introduction

Escherichia coli (E. coli) strains belonging to enterobacteriaceae family are normal habitant of gastro-intestinal tract in the wide range of warm-blooded hosts. Many E. coli strains are harmless while some are pathogenic, meaning that they can cause illness, either diarrhea or infections in extraintestinal sites such as urinary tract infections (UTI) in human (1, 2). After respiratory infections, the UTI’s are the most common infectious problem in human resulting in serious sequelae if remain untreated and Uropathogenic E. coli (UPEC) is responsible for more than %80 of UTI’s (3, 4). E. coli strains based on some genetic markers (chuA, yjaA, and tspE4.C2) are divided into four main phylogenetic groups A, B1, B2 and D consisting of seven phylotypes: phylotypes A0 and A1 (group A); B1 (group B1); B22 and B23 (group B2); D1 and D2 (group D) (5). It is believed that groups B2 and D include the majority of virulent extraintestinal E. coli, whilst groups A and B1 primarily represent commensal characteristics (6, 7). On the other hand, UPEC strains have multiple virulence factors (VFs) that confer the potential for pathogenicity, invasion, and colonization of urinary tract sites such as P and S fimbriae, afimbrial adhesion molecules and hemolysin through pathogenicity islands (8). There are some evidences demonstrating that sex and gender can imply an important role in the formation of microbiota of human flora sites. Pathogenic species and phenotypic characteristics causing UTI’s are affected by such factors like gender (9-12). Accordingly, in the present study, relationships between the presence of selected virulence genes and the phylogroup of E. coli strains implicated in men and women UTI cases were evaluated to assess if there are genotypic differences between E. coli isolates in these two hosts.

Materials and Methods

One hundred and sixty E. coli strains were isolated from patients (25 - 45 years old/both sexes) suspected to suffering UTI based on urologist’s diagnosis referring to diagnostic laboratories according to the protocol described by Bonadio et al (13). Then stock cultures were prepared from the E. coli isolates and stored in Luria-Bertani broth (Sigma-Aldrich) with 15% (v/v) glycerol at -20 °C until genotyping. Genomic DNA was extracted from E. coli strains with the rapid one-step extraction (ROSE) method (14) based on alkaline lysis of bacteria and phylogenetic group and phylotype of isolates were identified using a modified Triplex PCR-based assay optimized for detection of chuA, yjaA, and tspE4.C2 gene markers as previously described by Staji (15). Finally, the detection of four extraintestinal putative virulence genes (hly, iucD, sfa/focDE and pap) was carried out using a modified Tetraplex-PCR program as described by Staji et al previously (8). The primers sequences used in this study are present in Table 1.
Table 1

Polymerase chain reaction primers used to detect phylogenetic groups and extraintestinal virulence factors genes of E. coli in samples collected from male and female patients suffering UTI

Gene Name Primer sequence (5’ to 3’)Product size (bp)Reference (5, 23)
chuA GACGAACCAACGGTCAGGAT279Carlos et al., (2010)
TGCCGCCAGTACCAAAGACA
yjaA TGCCGCCAGTACCAAAGACA211,,
ATGGAGAATGCGTTCCTCAAC
tspE4.C2 GAGTAAGTTCGGGGCATTCA152,,
CGCGCCAACAAAGTATTACG
hly AACAAGGATAAGCACTGTTCTGGCT1177Adib et al., (2014)
ACCATATAAGCGGTCATTCCCGTCA
iucD TACCGGATTGTCATATGCAGACCGT602,,
AATATCTTCCTCCAGTCCGGAGAAG
Pap GCAACAGCAACGCTGGTTGCATCA336,,
AGAGAGAGCCACTCTTATACGGACA
Sfa/focDE CTCCGCAGAACTGGGTGCATCTTA410,,
CGCAGGAGTAATTACAAACCTGGCA
Differences in frequencies of phylogenetic groups and virulence markers among men and women isolates was evaluated using chi-squared tests (x2) on contingency tables and Fisher’s exact test with a significance level of P=0.05, using SPSS (version 21) software.

Results

A total of 160 E. coli isolates, 100 from females and 60 from male patients, were obtained from 240 urine samples (66.6%) of human cases suffering UTI, confirming that E. coli is dominant agent in development of urinary tract infections. All phylogenetic groups and phylotypes were found among isolates from both sex individuals in the general population, except for A0 phylotype which was absent in E. coli isolates from females (Table 2). Distribution of the phylogenetic group’s differed depending on the host sexuality. In females (n=100 strains), 46% of isolates belonged to group B2, 33% to group D, 13% to group A, and 8% to group B1. In male patients (n=60 strains), phylogroup B2 was predominant (48.3%) followed by phylogroups D (25%), A (20%) and group B1 (6.7%). Distribution of E. coli phylotypes are presented in Table 2 in detailed. Statistical analyses showed that there is no significant differences between distributions of phylogenetic groups in male and female isolates. Comparison of prevalence of phylotypes between both sexes shows that D2 phylotype is more prevalent in male isolates than females (P=0.045), significantly.
Table 2

Frequency of E. coli phylogenetic Types (PT) and virulence genes (%) in relation to PT among urinary E. coli isolates from human female and male UTI cases

SourcePTNo. Strains (%)Virulence Genes (%)
hly iucD Sfa/focDE pap
Female UTIA00----
A113 (13)06 (12.75)1 (2.3)1
B18 (8)1 (6.7)2 (4.2)5 (11.6)1
B225 (5)03 (6.4)1 (2.3)1
B2341 (41)12 (80)19 (40.5)23 (53.5)8
D112 (12)1 (6.7)5 (10.6)5 (11.6)1
D221 (21)1 (6.7)12 (25.5)8 (18.6)1
Total100 (100)15 (100)47 (100)43 (100)13 (100)
Male UTIA02 (3.3)0000
A110 (16.7)05 (14)00
B14 (6.7)02 (5.5)1 (7.7)1 (6.2)
B223 (5)02 (5.5)01 (6.2)
B2326 (43.3)4 (100)20 (55.5)11 (84.6)12 (75)
D110 (16.7)05 (14)01 (6.2)
D25 (8.3)02 (5.5)1 (7.7)1 (6.2)
Total60 (100)4 (100)36 (100)13 (100)16 (100)
The detection of virulence factors (hly; iucD; pap; sfa/focDE) using Multiplex-PCR revealed that 158 (98.75%) of all strains (n=160) were positive for at least 1 of the virulence genes tested; of these strains, 100 (100%) were female and 58 (96.6%) were male isolates. In the strains isolated from female patients, iucD and sfa/focDE were the most common virulence genes identified (47% and 43%, respectively), followed by hly (15%) and pap (13%). The only significant difference in the prevalence of virulence genes among female phylogroups showed that hly was significantly more prevalent in B2 compared to D phylogroup (P=0.034). In the male strains, iucD, pap and sfa/focDE were the most common virulence genes detected, present in 36%, 16% and 13% of isolates, respectively, and followed by hly (4%). In the E. coli isolates related to male patients sfa/focDE and pap (P=0.035 and P=0.048, respectively) were significantly more prevalent in B2 phylogroup compared to D. The prevalence of virulence genes in E. coli phylogroups and phylotypes of human UTI’s are present in Table 2. Statistical analyses on the prevalence of virulence factors between E. coli isolates, stratifying by host gender, showed that pap is more prevalent in male isolates (P=0.035) whereas sfa/focDE is more prevalent in female strains (P=0.006), significantly.

Discussion

E. coli is the predominant etiology of UTI and in this study a total of 160 E. coli isolates collected from the urine samples of female (62.5%) and male (37.5%) patients suffering from UTI caused by E. coli were examined to determine the phylogenetic group and phylotypes of each strains and the presence of the four extraintestinal pathogenic E. coli (ExPEC) related virulence genes. Finally, the distribution of phylogenetic characteristics and mentioned virulence genes were compared in E. coli strains of both sexes to investigate the differences in genotypes between the two sources. Polymerase chain reaction primers used to detect phylogenetic groups and extraintestinal virulence factors genes of E. coli in samples collected from male and female patients suffering UTI Frequency of E. coli phylogenetic Types (PT) and virulence genes (%) in relation to PT among urinary E. coli isolates from human female and male UTI cases All phylogenetic groups and subgroups were found among isolates from UTI’s and our results show that groups B2 (46.8%) and D (30%) are the most prevalent phylogenetic groups in E. coli strains implicated in human urinary tract infections (Table 2). These results are in parallel with some phylogenetic epidemiological studies about UPEC, as reported by Staji et al (8). It has been demonstrated that ExPEC strains usually belong to groups B2 and D. In our study about 23% of isolates belonged to groups A and B1. These findings are in accordance with the results of Bingen et al. and Pupo et al. demonstrating that the route of infection can be intestinal pathogenic E. coli and commensal strains (17, 18). Although there are some evidences about the impact of host gender on the pathogenic aspects of E. coli in UTIs (12) but there is no data about comparative phylogenomics of this pathogenic agent between male and female patients. The comparison of phylogenetic groups and phylotypes distribution between isolates from male and female cases demonstrated that the only significant difference is in D2 phylotype while it was more prevalent in male E. coli isolates from male UTI cases. The difference between D1 and D2 phylotypes is harboring tspE4.C2 genetic marker by D2 which its role in the pathogenesis is unclear (19). Any way considering tspE4.C2 as a virulence factor and higher distribution of this element in male UPEC, it can be concluded that UPEC strains in male patients are more virulent than female ones. Detection of virulence genes in the strains from UTI’s shows the presence of isolates harboring a combination of hly, iucD, pap and sfa/focDE genes, which could implicate the presence of Pathogenicity Islands (PAI’s) – typical chromosomal traits of the UPEC strains (8, 20). As expected, the majority of urinary strains (98.7%) harbored extraintestinal virulence factor-encoding genes and only 2 isolates (1.2%) in our study were negative for the mentioned virulence genes. Previous studies have assessed the prevalence of E. coli strains showing multiple virulence factors patterns implicated in extra-intestinal infections and they have concluded that this prevalence is strongly associated with strains belonging to phylogroup B2 (21, 22). Comparison of the virulence factors distribution in E. coli phylogroups from male and female’s demonstrated that in women isolates hly is significantly more prevalent in B2 group versus D, while in men isolates sfa/focDE and pap genes are more prevalent in B2 versus D, significantly. UPEC possess a diverse array of adherence factors and fimbriae such as type 1, P, F1C/S and AFA fimbriae represent the primary mediators for colonization of the urinary tract. An important step in the onset and expansion of UTI is adhesion of E. coli to uroepithelial cells by P fimbriae. S fimbriae has also been shown to attach efficiently to the epithelial and endothelial cells of the lower human urinary tract. Studies have shown that papEF and sfa/focDE are essential for cystitis and/or pyelonephritis (16, 23, 24). In the present study it is observed that papEF is more prevalent in male isolates, while in female isolates sfa/focDE is dominant, significantly. These results show that in men and women UTI caused by E. coli, the type of adhesion and fimbriae may quite be different and this can be because of anatomic differences and fimberial receptors on the epithelial cells of urinary tract. Also the comparison of distribution of these two adhesins in B2 and D phylogroups of this both genders shows that there is no difference in the type of adhesins in female isolates, but in male isolates presence of papEF and sfa/focDE is dominant in B2 phylogroup versus D, significantly. These findings confer that UPEC having any type of related adhesins belonging to B2 and D groups may be able to onset UTI in women but E. coli strains with pap and sfa/focDE belonging to B2 are more prone to induce UTI in men. Detection of iucD in E. coli isolates showed that 52% of tested strains are positive for this virulence factor, and assessment of this VF in different phylogroups showed that 82% of iucD are present in B2 and D groups. There was not any sex depended differences between distribution of iucD prevalence in E. coli isolates. About 48% of our isolates are lacking iucD, considering that ExPEC strains have evolved multiple strategies for sequestering iron from the host, probably they have other strategies for iron uptake from the host organs (25).

Conclusion

The results show that phylogroups B2 and D, are the major E. coli strains causing human urinary tract infections and strains causing such infections in different genders can vary in virulence genotypes, especially in type of adhesins for the colonization and onset of the infection. More work seems to be necessary for full genotyping of E. coli strains isolated from both sexes and assessment of antimicrobial resistance profile of such isolates from these two sources.
  20 in total

1.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2.

Authors:  Lixin Zhang; Betsy Foxman; Carl Marrs
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Current microbiological and clinical aspects of urinary tract infections.

Authors:  M Bonadio; M Meini; P Spitaleri; C Gigli
Journal:  Eur Urol       Date:  2001-10       Impact factor: 20.096

4.  Genetic characterization of Escherichia coli O157:H7 strains isolated from the one-humped camel (Camelus dromedarius) by using microarray DNA technology.

Authors:  Taghi Zahraei Salehi; Alfreda Tonelli; Alberto Mazza; Hamid Staji; Pietro Badagliacca; Iradj Ashrafi Tamai; Reza Jamshidi; Josée Harel; Rossella Lelli; Luke Masson
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

5.  Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland.

Authors:  K Hryniewicz; K Szczypa; A Sulikowska; K Jankowski; K Betlejewska; W Hryniewicz
Journal:  J Antimicrob Chemother       Date:  2001-06       Impact factor: 5.790

6.  Escherichia coli phylogenetic group determination and its application in the identification of the major animal source of fecal contamination.

Authors:  Camila Carlos; Mathias M Pires; Nancy C Stoppe; Elayse M Hachich; Maria I Z Sato; Tânia A T Gomes; Luiz A Amaral; Laura M M Ottoboni
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

7.  Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans.

Authors:  James R Johnson; Michael A Kuskowski; Krista Owens; Abby Gajewski; Patricia L Winokur
Journal:  J Infect Dis       Date:  2003-08-15       Impact factor: 5.226

8.  Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.

Authors:  Safar Farajnia; Mohammad Yousef Alikhani; Reza Ghotaslou; Behrooz Naghili; Ailar Nakhlband
Journal:  Int J Infect Dis       Date:  2008-08-13       Impact factor: 3.623

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.

Authors:  Justyna Bien; Olga Sokolova; Przemyslaw Bozko
Journal:  Int J Nephrol       Date:  2012-03-08
View more
  3 in total

1.  Virulence factors analysis and antibiotic resistance of uropathogenic Escherichia coli isolated from patients in northeast of Iran.

Authors:  Mahdis Ghavidel; Tahere Gholamhosseini-Moghadam; Kimiya Nourian; Kiarash Ghazvini
Journal:  Iran J Microbiol       Date:  2020-06

Review 2.  Phylogenetic Group Distribution of Uropathogenic Escherichia coli and Related Antimicrobial Resistance Pattern: A Meta-Analysis and Systematic Review.

Authors:  Mehrdad Halaji; Amirhossein Fayyazi; Mehdi Rajabnia; Donya Zare; Abazar Pournajaf; Reza Ranjbar
Journal:  Front Cell Infect Microbiol       Date:  2022-02-25       Impact factor: 5.293

3.  The relationship between phylogenetic groups and antibiotic susceptibility patterns of Escherichia coli strains isolated from feces and urine of patients with acute or recurrent urinary tract infection.

Authors:  Hossein Norouzian; Mohammad Katouli; Nader Shahrokhi; Sharam Sabeti; Mohammad Pooya; Saeid Bouzari
Journal:  Iran J Microbiol       Date:  2019-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.